Span Divergent Ltd
SDL · NSE · BSE 524727 · Healthcare
₹24.95−₹1.314.99%Prev. close ₹26.26
At close: 16 Nov 2026, 3:30 PM India time · NSE
- Market cap
- ₹19 Cr
- P/E (last FY)
- —
- Forward P/E
- —
- Open
- ₹26.26
- Day range
- ₹24.95 – ₹26.26
- 52W range
- ₹20.52 – ₹51.49
- EPS (last FY)
- ₹-4.79
- Dividend yield
- —
- Volume
- 121
- P/B
- 1.38
- ROE
- 14.4%
- Debt / equity
- 0.89
P/B is the price over the book value per share at Sept 2026.
News
Financials
Earnings
Valuation
Ownership
Business
Technicals
Your research
Span Divergent Ltd (SDL): company summary
The company's revenue rose 92.2% annually, but the latest quarter saw revenue fall 29.2% compared to the same quarter a year earlier.
Span Divergent Ltd (SDL) is a micro-cap Healthcare company valued at ₹19 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Span Divergent Ltd last traded at ₹24.95, down 4.99% on the day.
- Financial performance
- The company's revenue rose 92.2% annually, but the latest quarter saw revenue fall 29.2% compared to the same quarter a year earlier. Net profit widened from a ₹1 crore loss to a ₹3 crore loss annually, while the latest quarter's net loss widened from ₹0 crore to ₹1 crore.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 1.38 times book value.
- Things to watch
- The company's net profit margin narrowed 2.9 percentage points to -17.1%, and the latest quarter's net loss widened. The stock is 49.0% below its 52-week high, and the company reported a net loss of ₹3 crore in its latest financial year.
- Where it stands
- The company's revenue grew 92.2% annually, but the latest quarter's revenue fell 29.2% compared to the same quarter a year earlier. The latest quarter's net loss widened to ₹1 crore, and the stock is 49.0% below its 52-week high.
Summarised by DocStoX's model on 2026-11-15 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Explore Span Divergent Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Span Divergent Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedDr. Reddy's Laboratories LimitedCipla LimitedMankind Pharma LimitedAurobindo Pharma LimitedMax Healthcare Institute LimitedManipal Health Enterprises Limited
Compare Span Divergent Ltd with peers
Span Divergent Ltd vs Sun Pharmaceutical Industries LimitedSpan Divergent Ltd vs Divi's Laboratories LimitedSpan Divergent Ltd vs Torrent Pharmaceuticals LimitedSpan Divergent Ltd vs Laurus Labs LimitedSpan Divergent Ltd vs Apollo Hospitals Enterprise LimitedSpan Divergent Ltd vs Zydus Lifesciences Limited
Related tools & concepts
Value Span Divergent Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing

